Phase I Study of IMP321 Given Alone or as an Adjuvant to a Reference Flu Antigen

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00354263
Recruitment Status : Completed
First Posted : July 20, 2006
Last Update Posted : April 24, 2008
SGS Aster-Cephac (CRO)
Information provided by:
Immutep S.A.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2005
  Actual Study Completion Date : February 2006